Literature DB >> 30237022

Molecular Subtypes of Bladder Cancer: Academic Exercise or Clinical Relevance?

Lars Dyrskjøt1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30237022     DOI： 10.1016/j.eururo.2018.09.006

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  4 in total

1.  Clinical Parameters Outperform Molecular Subtypes for Predicting Outcome in Bladder Cancer: Results from Multiple Cohorts, Including TCGA.

Authors:  Daley S Morera; Sarrah L Hasanali; Daniel Belew; Santu Ghosh; Zachary Klaassen; Andre R Jordan; Jiaojiao Wang; Martha K Terris; Roni J Bollag; Axel S Merseburger; Arnulf Stenzl; Mark S Soloway; Vinata B Lokeshwar
Journal:  J Urol       Date:  2019-05-21       Impact factor: 7.450

Review 2.  Natural products as a means of overcoming cisplatin chemoresistance in bladder cancer.

Authors:  Ganeshkumar Rajendran; John A Taylor; Benjamin L Woolbright
Journal:  Cancer Drug Resist       Date:  2021-03-19

Review 3.  Molecular Oncology of Bladder Cancer from Inception to Modern Perspective.

Authors:  Soum D Lokeshwar; Maite Lopez; Semih Sarcan; Karina Aguilar; Daley S Morera; Devin M Shaheen; Bal L Lokeshwar; Vinata B Lokeshwar
Journal:  Cancers (Basel)       Date:  2022-05-24       Impact factor: 6.575

4.  Practicability of clinical application of bladder cancer molecular classification and additional value of epithelial-to-mesenchymal transition: prognostic value of vimentin expression.

Authors:  João Lobo; Sara Monteiro-Reis; Catarina Guimarães-Teixeira; Paula Lopes; Isa Carneiro; Carmen Jerónimo; Rui Henrique
Journal:  J Transl Med       Date:  2020-08-05       Impact factor: 5.531
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.